Method of decongesting the nose without adverse stimulant effect

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3142

Patent

active

049803646

ABSTRACT:
Disclosed is the use of (+/-)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline as a nasal decongestant which, when administered orally, does not produce adverse central nervous system stimulant effects as experienced with other decongestants and anorexiants.

REFERENCES:
patent: 3161650 (1964-12-01), Poos
patent: 4256755 (1981-03-01), Smith, Jr.
Chem. Abst., 83:91037v, (1975), Engelhardt et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of decongesting the nose without adverse stimulant effect does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of decongesting the nose without adverse stimulant effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of decongesting the nose without adverse stimulant effect will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1163011

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.